Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 9, 2000, Pages 2113-2119

  Tomás, Marta ^a   Sentí, Mariano ^a   García Faria, Ferrán ^b   Vila, Juan ^a   Torrents, Alex ^a   Covas, Maribel ^a   Marrugat, Jaume ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b ABS Llefià   (Spain)

Author keywords

Familial hypercholesterolemia; Paraoxonase; PON1 genotypes; Simvastatin

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHOLESTEROL; LIPID PEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PARAOXON; SIMVASTATIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033817620     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.9.2113     Document Type: Article

References (29)

1. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein
2. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase
3. A variant of a human paraoxonase arylesterase (HUMPONA) gene is a risk factor for coronary artery disease
4. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease
5. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation
6. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's thiols
7. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family
8. Paraoxonase: Biochemistry, genetics and relationship to plasma lipoproteins
9. Paraoxonase polymorphism Met-Leu54 is associated with modified concentrations of the enzyme: A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes
10. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction
11. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus
12. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus
13. Simvastatin decreases aldehyde production derived from lipoprotein oxidation
14. Purification of human serum paraoxonase/arylesterase
15. Measurement of serum lipid peroxidation during exercise using different methods: Diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids
16. A simple salting-out procedure for extracting DNA from human nucleated cells
17. The molecular basis of the human serum paraoxonase activity polymorphism
18. Risk of myocardial infarction for the association of the Gln/Arg 192 polymorphism of human paraoxonase gene and diabetes mellitus
19. The role of oxidized lipoprotein in atherogenesis
20. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
21. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia
22. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: Implications for the pathophysiology of apoB production
23. Clinical classification of lipid abnormalities
24. Quantification of human serum paraoxonase by enzyme-linked immunoassay: Population differences in protein concentrations
25. The separation of sheep and human 'A'-esterase activity into the lipoprotein fraction by ultracentrifugation
26. Apolipoprotein J is associated with paraoxonase in human plasma
27. Structure and stability of apolipoprotein J-containing high-density lipoproteins
28. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q 224 R genetic polymorphism
29. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants